Abstract
Selective decontamination of the digestive tract (SDD) is a prophylactic antibiotic regimen that is not widely used in practice. We aimed to describe the opinions of key 'stakeholders' about the validity of the existing evidence base, likely consequences of implementation, relative importance of their opinions in influencing overall practice, likely barriers to implementation and perceptions of the requirement for further research to inform the decision about whether to embark on a further large randomised controlled trial.
Original language | English |
---|---|
Article number | R266 |
Journal | Critical Care |
Volume | 17 |
Issue number | 6 |
DOIs | |
Publication status | Published - 8 Nov 2013 |